Alzheimer's Caregiver Coping: Mental and Physical Health
Alzheimer Disease, Alzheimer Dementia, Alzheimer's Disease
About this trial
This is an interventional treatment trial for Alzheimer Disease focused on measuring Dementia, Caregiver, Cardiovascular Disease, Stress, Depression, Anxiety, Heart Disease, Carer, Care Giver, Caregiving, Psychotherapy, Therapy, Behavioral Activation, Education, Intervention, CBT, Cognitive-Behavior Therapy
Eligibility Criteria
Inclusion Criteria:
- Aged 55 years or older.
- Providing in-home care to a spouse with dementia.
Exclusion Criteria:
- Taking Coumarin anticoagulants.
- Taking nitrates or niacin.
- Taking non-selective β-blockers.
- Glucocorticoid use in the 2 weeks prior to enrollment.
- Taking Aldomet or labetalol.
- Neither the caregiver nor Alzheimer's patient can be diagnosed with a terminal illness with a life expectancy of less than 1 year
- Cognitive impairment
- Caregivers enrolled in another intervention study or receiving psychotherapy to improve well-being or reduce distress
- Blood pressure >200/120 mm Hg
Sites / Locations
- University of California San Diego
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Behavioral Activation
Information and Support
Behavioral Activation (BA) emphasize self-monitoring as an aid for increasing one's engagement in self-reinforcing activities while simultaneously reducing negative avoidant coping responses. The intervention consists of 6 total face-to-face sessions lasting 60 minutes each.
Information and Support (IS) consists of providing education on Alzheimer's disease, coping with specific stresses prevalent in caregiving, and community-based services available for caregivers. Caregivers choose information most relevant to their current circumstances, and can discuss this with their counselor during the sessions. In addition, the IS condition encompasses elements of supportive therapy including empathy and active listening. The intervention consists of 6 total face-to-face sessions lasting 60 minutes each.